MGO One Seven’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
13,627
+1,804
+15% +$238K 0.03% 542
2026
Q1
$1.65M Buy
11,823
+821
+7% +$115K 0.03% 506
2025
Q4
$1.35M Buy
11,002
+2,606
+31% +$317K 0.03% 555
2025
Q3
$932K Buy
8,396
+2,003
+31% +$228K 0.02% 609
2025
Q2
$709K Sell
6,393
-2,313
-27% -$246K 0.02% 594
2025
Q1
$975K Sell
8,706
-2,489
-22% -$257K 0.04% 445
2024
Q4
$1.03M Buy
11,195
+4,639
+71% +$418K 0.04% 432
2024
Q3
$550K Buy
6,556
+80
+1% +$6.1K 0.02% 554
2024
Q2
$444K Buy
6,476
+928
+17% +$61.9K 0.02% 602
2024
Q1
$406K Sell
5,548
-953
-15% -$73.3K 0.02% 605
2023
Q4
$527K Sell
6,501
-196
-3% -$15.3K 0.03% 508
2023
Q3
$502K Sell
6,697
-781
-10% -$60.1K 0.04% 431
2023
Q2
$576K Sell
7,478
-3,343
-31% -$267K 0.05% 374
2023
Q1
$898K Sell
10,821
-33
-0.3% -$2.73K 0.06% 320
2022
Q4
$932K Buy
10,854
+1,368
+14% +$108K 0.09% 242
2022
Q3
$645 Buy
9,486
+2,541
+37% +$160K 0.03% 333
2022
Q2
$429K Buy
6,945
+1,638
+31% +$101K 0.06% 362
2022
Q1
$316K Buy
5,307
+495
+10% +$31.6K 0.03% 491
2021
Q4
$349K Buy
+4,812
New +$331K 0.04% 453
2019
Q1
Sell
-598
Closed -$37K 884
2018
Q4
$37K Buy
+598
New +$41.8K 0.02% 721
2018
Q1
$90K Buy
1,200
+129
+12% +$10.3K 0.04% 466
2017
Q4
$77K Buy
+1,071
New +$81.3K 0.04% 496

Other funds holding GILD

MGO One Seven's GILD Position: Q2 2026 in Review

MGO One Seven increased its Gilead Sciences (GILD) stake by 15% in Q2 2026, buying an estimated $238K and bringing the position to 13,627 shares worth $1.72M. The position accounts for 0.03% of the portfolio, ranked #542.

MGO One Seven first reported a position in GILD in Q4 2017 and has held it in 22 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MGO One Seven held 13,627 shares of Gilead Sciences worth $1.72M as of Q2 2026.
  • MGO One Seven bought 1,804 Gilead Sciences shares in Q2 2026, an estimated $238K.
  • Gilead Sciences made up 0.03% of MGO One Seven's portfolio in Q2 2026, its #542 holding.
  • MGO One Seven first reported a position in Gilead Sciences in Q4 2017 and has held it in 22 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.